Literature DB >> 11344573

Splanchnic glucose and amino acid metabolism in obesity.

P Felig1, J Wahren, R Hendler, T Brundin.   

Abstract

Arterial concentrations and splanchnic exchange of glucose, lactate, pyruvate, glycerol, free fatty acids, and individual acidic and neutral amino acids were determined in obese and nonobese control subjects in the basal state and during a 45 min infusion of glucose. Glucose was administered to the controls at a rate (2 mg/kg/min; 144 +/- 4 mg/min) known to inhibit splanchnic glucose output without influencing peripheral glucose utilization. The obese subjects received glucose at two dose levels (75 and 150 mg/min) which simulated either the rise in insulin or the inhibition in splanchnic glucose production observed in the controls. In the basal state splanchnic glucose production did not differ significantly between obese and control subjects. However splanchnic uptake of lactate, glycerol, alanine, free fatty acids, and oxygen was 50-160% greater in obese subjects. Splanchnic uptake of glucose precursors could account for 33% of hepatic glucose output in the obese group as compared to 19% in controls. The increase in alanine and lactate uptake was due in part, to a 50% increase in splanchnic fractional extraction. Administration of glucose to the control subjects 144 +/- 4 mg/min) resulted in a 50-60% increment in arterial insulin and a 75% reduction in splanchnic glucose output. In the obese group, infusion of glucose at a rate of 75 mg/min resulted in an equivalent rise in arterial insulin, but was accompanied by a less than 40% inhibition in splanchnic glucose output. Glucose infusion at a rate of 150 mg/min in the obese resulted in a 75% reduction in splanchnic glucose output which was equivalent to that observed in controls, but was accompanied by a significantly greater rise (100-200%) in arterial insulin. It is concluded that in obesity (a) despite basal hyperinsulinemia, splanchnic uptake of glucose precursors is increased, the relative contribution to total glucose release attributable to gluconeogenesis being 70% higher than in controls; (b) infusion of glucose at rates causing equivalent increases in arterial insulin induces a smaller inhibition in splanchnic glucose output than in controls; (c) infusion of glucose at rates causing comparable inhibition in splanchnic glucose output is accompanied by a disproportionately greater increase in endogenous insulin than in controls. These data are compatible with hepatic resistance to insulin in obesity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 11344573      PMCID: PMC301502          DOI: 10.1172/JCI107593

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Physiologic significance of the intravenous glucose tolerance test.

Authors:  J R FRANCKSON; H A OOMS; R BELLENS; V CONARD; P A BASTENIE
Journal:  Metabolism       Date:  1962-05       Impact factor: 8.694

Review 2.  The glucose-alanine cycle.

Authors:  P Felig
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

3.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

4.  Glucose kinetics in human obesity.

Authors:  J R Franckson; W Malaise; Y Arnould; E Rasio; H A Ooms; E Balasse; V Conard; P A Bastenie
Journal:  Diabetologia       Date:  1966-09       Impact factor: 10.122

5.  Glucose metabolism during leg exercise in man.

Authors:  J Wahren; P Felig; G Ahlborg; L Jorfeldt
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

6.  Turnover and oxidation of plasma glucose in lean and obese humans.

Authors:  P Paul; W M Bortz
Journal:  Metabolism       Date:  1969-07       Impact factor: 8.694

7.  Influence of dietary deprivations on plasma concentration of free amino acids of man.

Authors:  S A Adibi
Journal:  J Appl Physiol       Date:  1968-07       Impact factor: 3.531

8.  Plasma amino acid levels and insulin secretion in obesity.

Authors:  P Felig; E Marliss; G F Cahill
Journal:  N Engl J Med       Date:  1969-10-09       Impact factor: 91.245

9.  Alcohol hypoglycemia. V. Alcohol infusion to test gluconeogenesis in starvation, with special reference to obesity.

Authors:  R A Arky; N Freinkel
Journal:  N Engl J Med       Date:  1966-02-24       Impact factor: 91.245

10.  The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity.

Authors:  L B Salans; J L Knittle; J Hirsch
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

View more
  55 in total

1.  A simulation model of extracellular glucose distribution in the human body.

Authors:  J Tiran; K R Galle; D Porte
Journal:  Ann Biomed Eng       Date:  1975-03       Impact factor: 3.934

Review 2.  Emerging paradigms for understanding fatness and diabetes risk.

Authors:  Steven R Smith; Eric Ravussin
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

3.  Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus.

Authors:  J Wahren; P Felig; L Hagenfeldt
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

Review 4.  Metabolomics in human type 2 diabetes research.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-02       Impact factor: 4.592

5.  Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

Authors:  J P Hosker; D R Matthews; A S Rudenski; M A Burnett; P Darling; E G Bown; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Role of insulin in the regulation of leucine kinetics in the conscious dog.

Authors:  N N Abumrad; L S Jefferson; S R Rannels; P E Williams; A D Cherrington; W W Lacy
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

7.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

8.  Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle.

Authors:  Micah J Drummond; Jill A Bell; Satoshi Fujita; Hans C Dreyer; Erin L Glynn; Elena Volpi; Blake B Rasmussen
Journal:  Clin Nutr       Date:  2008-03-14       Impact factor: 7.324

9.  Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

Authors:  R A DeFronzo; V Soman; R S Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Deoxysphingoid bases as plasma markers in diabetes mellitus.

Authors:  Mariana Bertea; Markus F Rütti; Alaa Othman; Jaqueline Marti-Jaun; Martin Hersberger; Arnold von Eckardstein; Thorsten Hornemann
Journal:  Lipids Health Dis       Date:  2010-08-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.